XML 29 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidation of Sponsored Investment Products (Tables)
9 Months Ended
Sep. 30, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Consolidated Statement of Balance Sheets

The following tables reflect the impact of the consolidated sponsored investment products in the Condensed Consolidated Balance Sheets as of September 30, 2013 and December 31, 2012 respectively:

 

As of September 30, 2013  
     Balance Before
Consolidation of
Investment Products
    Consolidated
Investment
Products
    Eliminations
and
Adjustments (a)
    Balances as
Reported in
Condensed
Consolidated
Balance Sheet
 
($ in thousands)              

Current assets

   $ 399,485      $ 139,044 (1)    $ (77,391   $ 461,138   

Non-current assets

     140,496        —         —         140,496   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

   $ 539,981      $ 139,044      $ (77,391   $ 601,634   
  

 

 

   

 

 

   

 

 

   

 

 

 

Current liabilities

   $ 66,105      $ 42,824      $ (26   $ 108,903   

Non-current liabilities

     8,072        —         —         8,072   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

     74,177        42,824        (26     116,975   
  

 

 

   

 

 

   

 

 

   

 

 

 

Redeemable noncontrolling interest

     —         —         18,855        18,855   

Equity attributable to stockholders of the Company

     465,853        96,220        (96,220     465,853   

Non-redeemable noncontrolling interest

     (49                 (49
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and equity

   $ 539,981      $ 139,044      $ (77,391   $ 601,634   
  

 

 

   

 

 

   

 

 

   

 

 

 
As of December 31, 2012  
     Balance Before
Consolidation of
Investment Products
    Consolidated
Investment
Products
    Eliminations
and
Adjustments (a)
    Balances as
Reported in
Consolidated
Balance Sheet
 
($ in thousands)              

Current assets

   $ 161,286      $ 43,924      $ (40,384   $ 164,826   

Non-current assets

     167,923        —         —         167,923   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

   $ 329,209      $ 43,924      $ (40,384   $ 332,749   
  

 

 

   

 

 

   

 

 

   

 

 

 

Current liabilities

   $ 62,034      $ 364      $ 13      $ 62,411   

Other non-current liabilities

     22,704        —         —         22,704   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

     84,738        364        13        85,115   
  

 

 

   

 

 

   

 

 

   

 

 

 

Redeemable noncontrolling interest

     —         —         3,163        3,163   

Equity attributable to stockholders of the Company

     244,474        43,560        (43,560     244,474   

Non-redeemable noncontrolling interest

     (3     —         —         (3
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and equity

   $ 329,209      $ 43,924      $ (40,384   $ 332,749   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) Includes other current assets of $41.0 million related to unsettled fund share receivables of consolidated sponsored investment products at September 30, 2013.
Consolidated Statement of Operations

The following table reflects the impact of the consolidated sponsored investment products in the Condensed Consolidated Statement of Operations for the three and nine months ended September 30, 2013 and 2012:

 

For the Three Months Ended September 30, 2013  
     Balance Before
Consolidation of
Investment
Products
     Consolidated
Investment
Products
   

Eliminations

and

Adjustments (a)

    Balances as
Reported in
Condensed
Consolidated
Statement of
Operations
 
($ in thousands)                          

Total operating revenues

   $ 100,319       $ —       $ 90      $ 100,409   

Total operating expenses

     68,547         142        90        68,779   
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating income (loss)

     31,772         (142     —         31,630   
  

 

 

    

 

 

   

 

 

   

 

 

 

Total other non-operating income (expense)

     1,870         923        (554     2,239   

Income (loss) before income tax expense

     33,642         781        (554     33,869   

Income tax expense

     12,567         —         —         12,567   
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss)

     21,075         781        (554     21,302   

Noncontrolling interests

     14         —         (227     (213
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to the Company

   $ 21,089       $ 781      $ (781   $ 21,089   
  

 

 

    

 

 

   

 

 

   

 

 

 

 

For the Three Months Ended September 30, 2012  
     Balance Before
Consolidation of
Investment
Products
     Consolidated
Investment
Products
   

Eliminations

and

Adjustments (a)

    Balances as
Reported in
Condensed
Consolidated
Statement of
Operations
 
($ in thousands)                          

Total operating revenues

   $ 71,825       $ —       $ 126      $ 71,951   

Total operating expenses

     54,030         28        126        54,184   
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating income (loss)

     17,795         (28     —         17,767   
  

 

 

    

 

 

   

 

 

   

 

 

 

Total other non-operating income (expense)

     1,126         639        (611     1,154   

Income (loss) before income tax expense

     18,921         611        (611     18,921   

Income tax expense

     7,279         —         —         7,279   
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss)

     11,642         611        (611     11,642   

Noncontrolling interests

     —          —         —         —    
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to the Company

   $ 11,642       $ 611      $ (611   $ 11,642   
  

 

 

    

 

 

   

 

 

   

 

 

 

 

For the Nine Months Ended September 30, 2013                           
     Balance Before
Consolidation of
Investment
Products
     Consolidated
Investment
Products
   

Eliminations

and

Adjustments (a)

     Balances as
Reported in
Condensed
Consolidated
Statement of
Operations
 
($ in thousands)                           

Total operating revenues

   $ 282,575       $ —        $ 142       $ 282,717   

Total operating expenses

     202,557         406        142         203,105   
  

 

 

    

 

 

   

 

 

    

 

 

 

Operating income (loss)

     80,018         (406     —           79,612   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total other non-operating income (expense)

     705         (768     1,056         993   

Income (loss) before income tax expense

     80,723         (1,174     1,056         80,605   

Income tax expense

     30,335         —          —           30,335   
  

 

 

    

 

 

   

 

 

    

 

 

 

Net income (loss)

     50,388         (1,174     1,056         50,270   

Noncontrolling interests

     46         —          118         164   
  

 

 

    

 

 

   

 

 

    

 

 

 

Net income (loss) attributable to the Company

   $ 50,434       $ (1,174   $ 1,174       $ 50,434   
  

 

 

    

 

 

   

 

 

    

 

 

 

 

For the Nine Months Ended September 30, 2012                         
    

Balance Before
Consolidation of
Investment

Products

    Consolidated
Investment
Products
    Eliminations
and
Adjustments (a)
    Balances as
Reported in
Condensed
Consolidated
Statement of
Operations
 

Total operating revenues

   $ 201,041      $ —        $ 126      $ 201,167   

Total operating expenses

     161,040        28        126        161,194   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss)

     40,001        (28     —          39,973   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other non-operating income (expense)

     1,938        639        (611     1,966   

Income (loss) before income tax expense

     41,939        611        (611     41,939   

Income tax expense

     16,480        —          —          16,480   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

     25,459        611        (611     25,459   

Allocation of earnings to preferred stockholders

     (64     —          —          (64
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to the Company

   $ 25,395      $ 611      $ (611   $ 25,395   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Adjustments include the elimination of intercompany transactions between the Company and its consolidated sponsored investment products, primarily the elimination of the investments and equity and recording of any noncontrolling interest.